NewAmsterdam Pharma enters $150M ATM equity offering with TD Cowen as agent

NewAmsterdam Pharma Co N.V.

Amended Sales Agreement replaces Cowen and Company with TD Cowen as sole sales agent.
Company may issue and sell up to $150M in ordinary shares at market prices via ATM offering.
No shares were sold under the prior December 2023 sales agreement.
TD Cowen receives up to 3% commission on gross sales; company has no obligation to sell.
Sales may be made through an affiliate of TD Cowen; agreement terminable at will by either party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.